by in
Entry Author Date Location
Sarepta Holds Its Breath as Feds Order Halt to Ebola Work 08/07/12 Seattle
Halo Gathers $1.1M From Patient Groups for Muscular Dystrophy Drug 05/24/12 Boston
Retrophin, Headed by Controversial Hedge Fund Chief, Raises $4M 05/07/12 New York
N-Gene Digs Up Funds to Boost “Heat Shock” Drug in Diabetes and MD 04/25/12 New York
AVI Biopharma Mulls Deal After Mixed Data With Muscular Dystrophy Drug 04/06/12 Seattle
Hard-Nosed Hedge Fund Chief Has Soft Spot for Rare-Disease Startup 04/03/12 New York
AVI Biopharma Passes Small Study in Muscular Dystrophy 04/02/12 Seattle
AVI Biopharma Axes 28% of Workforce, After Missing Out on Flu Contract 12/12/11 Seattle
AVI Biopharma CEO Chris Garabedian Seeks to Avoid Quick Flip, Build Enduring Drug Company 06/02/11 Seattle
Shire Finds Big Value in Rare Diseases, and a Strong Growth Path for its Boston Unit 05/12/11 New York
Acceleron Pharma Cuts 40 Percent of Workforce 11/03/10 Boston
Acceleron Weans Itself Off VC, Continues its Roll with Pharma Partner Dollars 09/28/10 Boston
Genzyme Sheds Testing Unit, Red Bend Acquires VirtualLogix, Acceleron Forges Alliance with Shire, & More Boston-Area Deals News 09/15/10 Boston
Acceleron Snags $498M Deal With Shire to Develop Muscular Dystrophy Drugs 09/09/10 Boston
Genentech Inks Antibody Deal, Cytokinetics Sticks With Science First, BioMarin Scraps Drug, & More Bay Area Life Sciences News 08/06/10 San Francisco
BioMarin Scraps Muscular Dystrophy Drug 08/02/10 San Francisco
AVI Biopharma Ousts CEO, CombiMatrix Drops Seattle Wing, Cell Therapeutics Cans 36 Workers, & More Seattle-Area Life Sciences News 04/22/10 Seattle
Cell Therapeutics Nears Judgment Day, AVI Biopharma Awaits Results, HemaQuest Gets $6M & More Seattle-Area Life Sciences News 02/04/10 Seattle
AVI Nails Down $30M 08/20/09 Seattle
AVI Bolts to Seattle, OncoGenex Escapes Dendreon’s Shadow, Buddhists Helping Biotech, & More Seattle-Area Life Sciences News 08/06/09 Seattle
AVI Biopharma Bolts from Portland to Seattle to Tap Biotech Talent 07/30/09 Seattle
Dendreon’s Former Boss Predicts Takeover, Covance Buys Merck Lab, How NanoString Got $30M, & More Seattle-Area Life Sciences News 07/30/09 Seattle
AVI Gets Duchenne Funding 07/28/09 Seattle
Dendreon Resists Urge to Sell Out, NanoString Nabs $30M, VC Firm Cashes Out on OncoGenex, & More Seattle-Area Life Sciences News 06/11/09 Seattle
AVI Gets $3M For Muscular Dystrophy 06/04/09 Seattle
Dendreon’s Hiring Binge, Calistoga’s Venture Round, ZymoGenetics Unloads Drugs, & More Seattle-Area Life Sciences News 05/07/09 Seattle
AVI Biopharma Out to Reinvent Itself, Making RNA-based Drugs for Ebola and Other Nasty Things 09/10/08 Seattle
Page 2 of 2 « previous page